TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

Ali I. Kuraishy, Samuel W. French, Mara Sherman, Marco Herling, Dan Jones, Randolph Wall, Michael A. Teitell

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aberrant expression of the TCL1 oncoprotein promotes malignant transformation of germinal center (GC) B cells. Repression of TCL1 in GC B cells facilitates FAS-mediated apoptosis and prevents lymphoma formation. However, the mechanism for this repression is unknown. Here we show that the CREB coactivator TORC2 directly regulates TCL1 expression independent of CREB Ser-133 phosphorylation and CBP/p300 recruitment. GC signaling through CD40 or the BCR, which activates pCREB-dependent genes, caused TORC2 phosphorylation, cytosolic emigration, and TCL1 repression. Signaling via cAMP-inducible pathways inhibited TCL1 repression and reduced apoptosis, consistent with a prosurvival role for TCL1 before GC selection and supporting an initiating role for aberrant TCL1 expression during GC lymphomagenesis. Our data indicate that a novel CREB/TORC2 regulatory mode controls the normal program of GC gene activation and repression that promotes B cell development and circumvents oncogenic progression. Our results also reconcile a paradox in which signals that activate pCREB/CBP/p300 genes concurrently repress TCL1 to initiate its silencing.

Original languageEnglish (US)
Pages (from-to)10175-10180
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number24
DOIs
StatePublished - Jun 12 2007
Externally publishedYes

Fingerprint

Germinal Center
Oncogene Proteins
B-Lymphocytes
Phosphorylation
Apoptosis
Emigration and Immigration
Transcriptional Activation
Genes
TOR complex 2
Lymphoma

Keywords

  • Gene regulation
  • Lymphomagenesis
  • Signal transduction

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. / Kuraishy, Ali I.; French, Samuel W.; Sherman, Mara; Herling, Marco; Jones, Dan; Wall, Randolph; Teitell, Michael A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 24, 12.06.2007, p. 10175-10180.

Research output: Contribution to journalArticle

Kuraishy, Ali I. ; French, Samuel W. ; Sherman, Mara ; Herling, Marco ; Jones, Dan ; Wall, Randolph ; Teitell, Michael A. / TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. In: Proceedings of the National Academy of Sciences of the United States of America. 2007 ; Vol. 104, No. 24. pp. 10175-10180.
@article{de95fc02bdfe4d688e91199c261b3164,
title = "TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation",
abstract = "Aberrant expression of the TCL1 oncoprotein promotes malignant transformation of germinal center (GC) B cells. Repression of TCL1 in GC B cells facilitates FAS-mediated apoptosis and prevents lymphoma formation. However, the mechanism for this repression is unknown. Here we show that the CREB coactivator TORC2 directly regulates TCL1 expression independent of CREB Ser-133 phosphorylation and CBP/p300 recruitment. GC signaling through CD40 or the BCR, which activates pCREB-dependent genes, caused TORC2 phosphorylation, cytosolic emigration, and TCL1 repression. Signaling via cAMP-inducible pathways inhibited TCL1 repression and reduced apoptosis, consistent with a prosurvival role for TCL1 before GC selection and supporting an initiating role for aberrant TCL1 expression during GC lymphomagenesis. Our data indicate that a novel CREB/TORC2 regulatory mode controls the normal program of GC gene activation and repression that promotes B cell development and circumvents oncogenic progression. Our results also reconcile a paradox in which signals that activate pCREB/CBP/p300 genes concurrently repress TCL1 to initiate its silencing.",
keywords = "Gene regulation, Lymphomagenesis, Signal transduction",
author = "Kuraishy, {Ali I.} and French, {Samuel W.} and Mara Sherman and Marco Herling and Dan Jones and Randolph Wall and Teitell, {Michael A.}",
year = "2007",
month = "6",
day = "12",
doi = "10.1073/pnas.0704170104",
language = "English (US)",
volume = "104",
pages = "10175--10180",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "24",

}

TY - JOUR

T1 - TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation

AU - Kuraishy, Ali I.

AU - French, Samuel W.

AU - Sherman, Mara

AU - Herling, Marco

AU - Jones, Dan

AU - Wall, Randolph

AU - Teitell, Michael A.

PY - 2007/6/12

Y1 - 2007/6/12

N2 - Aberrant expression of the TCL1 oncoprotein promotes malignant transformation of germinal center (GC) B cells. Repression of TCL1 in GC B cells facilitates FAS-mediated apoptosis and prevents lymphoma formation. However, the mechanism for this repression is unknown. Here we show that the CREB coactivator TORC2 directly regulates TCL1 expression independent of CREB Ser-133 phosphorylation and CBP/p300 recruitment. GC signaling through CD40 or the BCR, which activates pCREB-dependent genes, caused TORC2 phosphorylation, cytosolic emigration, and TCL1 repression. Signaling via cAMP-inducible pathways inhibited TCL1 repression and reduced apoptosis, consistent with a prosurvival role for TCL1 before GC selection and supporting an initiating role for aberrant TCL1 expression during GC lymphomagenesis. Our data indicate that a novel CREB/TORC2 regulatory mode controls the normal program of GC gene activation and repression that promotes B cell development and circumvents oncogenic progression. Our results also reconcile a paradox in which signals that activate pCREB/CBP/p300 genes concurrently repress TCL1 to initiate its silencing.

AB - Aberrant expression of the TCL1 oncoprotein promotes malignant transformation of germinal center (GC) B cells. Repression of TCL1 in GC B cells facilitates FAS-mediated apoptosis and prevents lymphoma formation. However, the mechanism for this repression is unknown. Here we show that the CREB coactivator TORC2 directly regulates TCL1 expression independent of CREB Ser-133 phosphorylation and CBP/p300 recruitment. GC signaling through CD40 or the BCR, which activates pCREB-dependent genes, caused TORC2 phosphorylation, cytosolic emigration, and TCL1 repression. Signaling via cAMP-inducible pathways inhibited TCL1 repression and reduced apoptosis, consistent with a prosurvival role for TCL1 before GC selection and supporting an initiating role for aberrant TCL1 expression during GC lymphomagenesis. Our data indicate that a novel CREB/TORC2 regulatory mode controls the normal program of GC gene activation and repression that promotes B cell development and circumvents oncogenic progression. Our results also reconcile a paradox in which signals that activate pCREB/CBP/p300 genes concurrently repress TCL1 to initiate its silencing.

KW - Gene regulation

KW - Lymphomagenesis

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=34547145931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547145931&partnerID=8YFLogxK

U2 - 10.1073/pnas.0704170104

DO - 10.1073/pnas.0704170104

M3 - Article

C2 - 17548807

AN - SCOPUS:34547145931

VL - 104

SP - 10175

EP - 10180

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 24

ER -